The cathepsin D gene exon 2 (C224T) polymorphism and sporadic Alzheimer's disease in European populations

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 60, Issue 8, 2005, Pages 991-996

  Capurso, Cristiano ^a,b   Solfrizzi, Vincenzo ^b   D'Introno, Alessia ^b   Colacicco, Anna M ^b   Capurso, Sabrina A ^b   Mastroianni, Franco ^b   Liaci, Maria ^b   Vendemiale, Gianluigi ^a   Capurso, Antonio ^b   Panza, Francesco ^b  

^a UNIVERSITY OF FOGGIA   (Italy)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CATHEPSIN D;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; EUROPE; EXON; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL;

EID: 24144488316     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/60.8.991     Document Type: Article

References (39)

1. Cataldo AM, Bamett JL, Pieroni C, Nixon RA. Increased neuronal endocytosis and protease delivery to early endosomes in sporadic Alzheimer's disease: neuropathologic evidence for a mechanism of increased beta-amyloidogenesis. J Neurosci. 1997;17:6142-6151.
2. Chevallier N, Vizzavona J, Marambaud P, et al. Cathepsin D displays in vitro β-secretase-like specificity. Brain Res. 1997;750:11-19.
3. Evin G, Cappai R, Li QX, et al. Candidate gamma-secretases in the generation of the carboxyl terminus of the Alzheimer's disease beta A4 amyloid: possible involvement of cathepsin D. Biochemistry. 1995;34:14185-14192.
4. McDermott JR, Gibson AM. Degradation of Alzheimer's beta-amyloid protein by human cathepsin D. Neuroreport. 1996;7:2163-2166.
5. Callahan LM, Vaules WA, Coleman PD. Quantitative decrease in synaptophysin message expression and increase in cathepsin D message expression in Alzheimer disease neurons containing neurofibrillary tangles. J Neuropathol Exp Neurol. 1999;58:275-287.
6. Kenessey A, Nacharaju P, Ko LW, Yen SH. Degradation of tau by lysosomal enzyme cathepsin D: implication for Alzheimer neurofibrillary degeneration. J Neurochem. 1997;69:2026-2038.
7. Wischik CM, Novak M, Thogersen HC, et al. Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease. Proc Natl Acad Sci U S A. 1988;85:4506-4510.
8. Papassotiropoulos A, Bagli M, Feder O, et al. Genetic polymorphism of cathepsin D is strongly associated with the risk for developing sporadic Alzheimer's disease. Neurosci Lett. 1999;262:171-174.
9. Papassotiropoulos A, Bagli M, Kurz A, et al. A genetic variation of cathepsin D is a major risk factor for Alzheimer's disease. Ann Neurol. 2000;47:399-403.
10. McIlroy SP, Dynan KB, McGleenon BM, Lawson JT, Passmore AP. Cathepsin D gene exon 2 polymorphism and sporadic Alzheimer's disease. Neurosci Lett. 1999;273:140-141.
11. Menzer G, Muller-Thomsen T, Meins W, et al. Non-replication of association between cathepsin D genotype and late onset Alzheimer disease. Am J Med Genet. 2001;105:179-182.
12. Bertram L, Guenette S, Jones J, et al. No evidence for genetic association or linkage of the cathepsin D (CTSD) exon 2 polymorphism and Alzheimer disease. Ann Neurol. 2001;49:114-116.
13. Bhojak TJ, DeKosky ST, Ganguli M, Kamboh MI. Genetic polymorphisms in the cathespin D and interleukin-6 genes and the risk of Alzheimer's disease. Neurosci Lett. 2000;288:21-24.
14. Mateo I, Sanchez-Guerra M, Combarros O, et al. Lack of association between cathepsin D genetic polymorphism and Alzheimer disease in a Spanish sample. Am J Med Genet. 2002;114:31-33.
15. Matsui T, Morikawa Y, Tojo M, et al. Cathepsin D polymorphism not associated with Alzheimer's disease in Japanese. Ann Neurol. 2001;49:544-545.
16. Styczynska M, Religa D, Pfeffer A, et al. Simultaneous analysis of five genetic risk factors in Polish patients with Alzheimer's disease. Neurosci Lett. 2003;344:99-102.
17. Prince JA, Feuk L, Sawyer SL, et al. Lack of replication of association findings in complex disease: an analysis of 15 polymorphisms in prior candidate genes for sporadic Alzheimer's disease. Eur J Hum Genet. 2001;9:437-444.
18. Bagnoli S, Nacmias B, Tedde A, et al. Cathepsin D polymorphism in Italian sporadic and familial Alzheimer's disease. Neurosci Lett. 2002;328:273-276.
19. Ingegni T, Nocentini G, Mariani E, et al. Cathepsin D polymorphism in Italian elderly subjects with sporadic late-onset Alzheimer's disease. Dement Geriatr Cogn Disord. 2003;16:151-155.
20. Emahazion T, Feuk L, Jobs M, et al. SNP association studies in Alzheimer's disease highlight problems for complex disease analysis. Trends Genet. 2001;17:407-413.
21. Li XQ, Chen D, Zhang ZX, Qu QM, Zhang JW. Association between cathepsin D polymorphism and Alzheimer's disease in a Chinese Han population. Dement Geriatr Cogn Disord. 2004;18:115-119.
22. Crawford FC, Freeman MJ, Schinka J, et al. The genetic association between cathepsin D and Alzheimer's disease. Neurosci Lett. 2000;289:61-65.
23. Papassotiropoulos A, Lewis HD, Bagli M, et al. Cerebrospinal fluid levels of beta-amyloid(42) in patients with Alzheimer's disease are related to the exon 2 polymorphism of the cathepsin D gene. Neuroreport. 2002;13:1291-1294.
24. Payton A, Holland F, Diggle P, et al. Cathepsin D exon 2 polymorphism associated with general intelligence in a healthy older population. Mol Psychiatry. 2003;8:14-18.
25. Panza F, Solfrizzi V, Torres F, et al. Apolipoprotein E in Southern Italy: protective effect of epsilon 2 allele in early- and late-onset sporadic Alzheimer's disease. Neurosci Lett. 2000;292:79-82.
26. Panza F, D'Introno A, Colacicco AM, et al. Regional European differences in allele and genotype frequencies of low density lipoprotein receptor-related protein 1 polymorphism in Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet. 2004;126:69-73.
27. Panza F, D'Introno A, Colacicco AM, et al. LBP-1c/CP2/LSF gene polymorphism and risk of sporadic Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2004;75:166-168.
28. D'Introno A, Solfrizzi V, Colacicco AM, et al. Polymorphisms in the oxidized low-density lipoprotein receptor-1 gene and risk of Alzheimer's disease. J Gerontol A Biol Sci Med Sci 2005;60:280-284.
29. Solfrizzi V, Panza F, D'Introno A, et al. Lipoprotein(a), apolipoprotein E genotype, and risk of Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2002;72:732-736.
30. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology. 1984;34:939-944.
31. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry. 1982;140:566-572.
32. Loeb C, Gandolfo C. Diagnostic evaluation of degenerative and vascular dementia. Stroke. 1983;14:399-401.
33. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62.
34. Panza F, Solfrizzi V, Torres F, et al. Decreased frequency of apolipoprotein E epsilon4 allele from Northern to Southern Europe in Alzheimer's disease patients and centenarians. Neurosci Lett. 1999;277:53-56.
35. Ntais C, Polycarpou A, Ioannidis JP. Meta-analysis of the association of the cathepsin D Ala224Val gene polymorphism with the risk of Alzheimer's disease: a HuGE gene-disease association review. Am J Epidemiol. 2004;159:527-536.
36. Hu Q, Kukull WA, Bressler SL, et al. The human FE65 gene: genomic structure and an intronic biallelic polymorphism associated with sporadic dementia of the Alzheimer type. Hum Genet. 1998;103:295-303.
37. Papassotiropoulos A, Bagli M, Becker K, et al. No association between an intronic biallelic polymorphism of the FE65 gene and Alzheimer's disease. Int J Mol Med. 2000;6:587-589.
38. Panza F, Solfrizzi V, D'Introno A, et al. Shifts in angiotensin I converting enzyme insertion allele frequency across Europe: implications for Alzheimer's disease risk. J Neurol Neurosurg Psychiatry. 2003;74:1159-1161.
39. Capurso C, Solfrizzi V, D'Introno A, et al. Interleukin 6-174 G/C promoter gene polymorphism and sporadic Alzheimer's disease: geographic allele and genotype variations in Europe. Exp Gerontol. 2004;39:1567-1573.